Top Markets
#1 Pleasing Gold Pleasing Gold +1,539.77%
#2 PulseChain PulseChain +58.48%
#3 Merlin's Seal BTC Merlin's Seal BTC +32.68%
#4 BOOK OF MEME BOOK OF MEME +30.73%
#5 Ontology Gas Ontology Gas +26.62%
#6 Pump.fun Pump.fun +23.00%
#7 Unit Pump Unit Pump +23.00%
#8 Nockchain Nockchain +21.29%
#9 RSK Infrastructure Framework RSK Infrastructure Framework +20.46%
#10 Neiro Neiro +20.13%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
Faeth Therapeutics, Inc. Faeth Therapeutics, Inc.

Faeth Therapeutics, Inc.

FTH
Rank in Stocks #26773
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on... Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
Share Price
$28.27
Last synced: 2026-08-11
Market Cap
$37.93M
Change (1 day)
-1.07%
Change (1 year)
255.09%
Country
US
Trade Faeth Therapeutics, Inc. (FTH)

Category

Healthcare
EPS for Faeth Therapeutics, Inc. (FTH)
EPS as of 2026 TTM: 0
According to Faeth Therapeutics, Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Faeth Therapeutics, Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH